THE PRESENT INVENTION RELATES TO METHODS OF REDUCING CARDIOTOXICITY AND/OR IMPROVING SURVIVAL FROM TREATMENT WITH ANTHRACYCLINE AGENTS COMPRISING ADMINISTERING A THERAPEUTICALLY EFFECTIVE AMOUNT OF A COMPOSITION COMPRISING A VASOPRESSIN ANTAGONIST COMPOUND OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS AN ACTIVE INGREDIENT, ADMINISTERED SIMULTANEOUSLY OR PRIOR TO THE ANTHRACYCLINE ADMINISTRATION. FIGURE 1